BPI 2026 has ended. This guide stays up as the record of who was there. Next: BPI 2027, Sep 20–23, 2027 in Boston
Johnson & Johnson at BPI 2026
Sep 22–25, 2026 Boston, MA ~3k attendees Website
Johnson & Johnson takes part in 3 sessions at BPI 2026 in Boston. Its program concerns antibody product quality and cell line strategy. Sessions examine galactosylation of the antibody Fc region and host cell protein challenges in antibody manufacturing, and ask whether cell lines for multispecifics and gene therapy are still built with monoclonal antibody thinking.
| Organization | BPI 2026 Attendance |
|---|---|
Johnson & Johnson New Brunswick, New Jersey | |
Global healthcare company whose Innovative Medicine segment develops, manufactures and markets pharmaceuticals including antibodies and cell therapies. | Talk Wed Sep 23 9:00am–9:30am Talk Thu Sep 24 2:15pm–2:45pm |
Find decision makers at Johnson & Johnson
Tell us what you sell and we’ll find the people at Johnson & Johnson most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the BioProcess International Conference & Exhibition or its organizers. Submit a correction